Assessment of IP injection of [18F]fallypride for behavioral neuroimaging in rats

Karmen Yoder, Bruce H. Mock, Qi-Huang Zheng, Brian P. McCarthy, Amanda A. Riley, Gary Hutchins

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Great progress has been made toward using small animal PET to assess neurochemical changes during behavior. [18F]fallypride (FAL) is a D2/D3 antagonist that is sensitive to changes in endogenous dopamine, and, in theory, could be used to assess changes in dopamine during behavioral paradigms. Tail vein injections of tracer require restraint in awake animals, and catheter implantation is invasive and can cause logistical problems. Thus, administering tracer with IP injections (which are well-tolerated by rodents) would be preferable. The purpose of this study was to determine whether IP injection of FAL would produce striatal uptake similar to that seen with traditional IV tail vein injection protocols. Four male Sprague-Dawley rats underwent IP injection of FAL, followed by a 30-min uptake and subsequent dynamic image acquisition on the IndyPET III small animal scanner. Three of these rats also received traditional dynamic scanning with IV FAL injection via a tail vein. Two rats that received IP injection had moderate striatal uptake, with striatum/cerebellum ratios (SUVR) that were only ∼20% lower than ratios from IV scans. Two other rats had little to no uptake; SUVR values were ∼70% lower than IV SUVR. These latter two animals showed heavy bone uptake, evidence of defluorination of FAL. The results of this pilot study suggest that it may be possible to achieve striatal uptake of FAL after IP injection. However, this was not seen consistently across animals. Future studies are needed to validate, and then to optimize, the use of IP FAL for behavioral imaging protocols.

Original languageEnglish
Pages (from-to)70-75
Number of pages6
JournalJournal of Neuroscience Methods
Volume196
Issue number1
DOIs
StatePublished - Mar 15 2011

Fingerprint

Neuroimaging
Injections
Corpus Striatum
Tail
Veins
Dopamine
N-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide
Cerebellum
Sprague Dawley Rats
fallypride
Rodentia
Catheters
Bone and Bones

Keywords

  • Behavioral neuroimaging
  • D2 receptor
  • Dopamine
  • Fallypride
  • Positron emission tomography
  • Small animal imaging

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Assessment of IP injection of [18F]fallypride for behavioral neuroimaging in rats. / Yoder, Karmen; Mock, Bruce H.; Zheng, Qi-Huang; McCarthy, Brian P.; Riley, Amanda A.; Hutchins, Gary.

In: Journal of Neuroscience Methods, Vol. 196, No. 1, 15.03.2011, p. 70-75.

Research output: Contribution to journalArticle

@article{e3187692ab1d43259e4e9d5c4682005e,
title = "Assessment of IP injection of [18F]fallypride for behavioral neuroimaging in rats",
abstract = "Great progress has been made toward using small animal PET to assess neurochemical changes during behavior. [18F]fallypride (FAL) is a D2/D3 antagonist that is sensitive to changes in endogenous dopamine, and, in theory, could be used to assess changes in dopamine during behavioral paradigms. Tail vein injections of tracer require restraint in awake animals, and catheter implantation is invasive and can cause logistical problems. Thus, administering tracer with IP injections (which are well-tolerated by rodents) would be preferable. The purpose of this study was to determine whether IP injection of FAL would produce striatal uptake similar to that seen with traditional IV tail vein injection protocols. Four male Sprague-Dawley rats underwent IP injection of FAL, followed by a 30-min uptake and subsequent dynamic image acquisition on the IndyPET III small animal scanner. Three of these rats also received traditional dynamic scanning with IV FAL injection via a tail vein. Two rats that received IP injection had moderate striatal uptake, with striatum/cerebellum ratios (SUVR) that were only ∼20{\%} lower than ratios from IV scans. Two other rats had little to no uptake; SUVR values were ∼70{\%} lower than IV SUVR. These latter two animals showed heavy bone uptake, evidence of defluorination of FAL. The results of this pilot study suggest that it may be possible to achieve striatal uptake of FAL after IP injection. However, this was not seen consistently across animals. Future studies are needed to validate, and then to optimize, the use of IP FAL for behavioral imaging protocols.",
keywords = "Behavioral neuroimaging, D2 receptor, Dopamine, Fallypride, Positron emission tomography, Small animal imaging",
author = "Karmen Yoder and Mock, {Bruce H.} and Qi-Huang Zheng and McCarthy, {Brian P.} and Riley, {Amanda A.} and Gary Hutchins",
year = "2011",
month = "3",
day = "15",
doi = "10.1016/j.jneumeth.2010.12.027",
language = "English",
volume = "196",
pages = "70--75",
journal = "Journal of Neuroscience Methods",
issn = "0165-0270",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Assessment of IP injection of [18F]fallypride for behavioral neuroimaging in rats

AU - Yoder, Karmen

AU - Mock, Bruce H.

AU - Zheng, Qi-Huang

AU - McCarthy, Brian P.

AU - Riley, Amanda A.

AU - Hutchins, Gary

PY - 2011/3/15

Y1 - 2011/3/15

N2 - Great progress has been made toward using small animal PET to assess neurochemical changes during behavior. [18F]fallypride (FAL) is a D2/D3 antagonist that is sensitive to changes in endogenous dopamine, and, in theory, could be used to assess changes in dopamine during behavioral paradigms. Tail vein injections of tracer require restraint in awake animals, and catheter implantation is invasive and can cause logistical problems. Thus, administering tracer with IP injections (which are well-tolerated by rodents) would be preferable. The purpose of this study was to determine whether IP injection of FAL would produce striatal uptake similar to that seen with traditional IV tail vein injection protocols. Four male Sprague-Dawley rats underwent IP injection of FAL, followed by a 30-min uptake and subsequent dynamic image acquisition on the IndyPET III small animal scanner. Three of these rats also received traditional dynamic scanning with IV FAL injection via a tail vein. Two rats that received IP injection had moderate striatal uptake, with striatum/cerebellum ratios (SUVR) that were only ∼20% lower than ratios from IV scans. Two other rats had little to no uptake; SUVR values were ∼70% lower than IV SUVR. These latter two animals showed heavy bone uptake, evidence of defluorination of FAL. The results of this pilot study suggest that it may be possible to achieve striatal uptake of FAL after IP injection. However, this was not seen consistently across animals. Future studies are needed to validate, and then to optimize, the use of IP FAL for behavioral imaging protocols.

AB - Great progress has been made toward using small animal PET to assess neurochemical changes during behavior. [18F]fallypride (FAL) is a D2/D3 antagonist that is sensitive to changes in endogenous dopamine, and, in theory, could be used to assess changes in dopamine during behavioral paradigms. Tail vein injections of tracer require restraint in awake animals, and catheter implantation is invasive and can cause logistical problems. Thus, administering tracer with IP injections (which are well-tolerated by rodents) would be preferable. The purpose of this study was to determine whether IP injection of FAL would produce striatal uptake similar to that seen with traditional IV tail vein injection protocols. Four male Sprague-Dawley rats underwent IP injection of FAL, followed by a 30-min uptake and subsequent dynamic image acquisition on the IndyPET III small animal scanner. Three of these rats also received traditional dynamic scanning with IV FAL injection via a tail vein. Two rats that received IP injection had moderate striatal uptake, with striatum/cerebellum ratios (SUVR) that were only ∼20% lower than ratios from IV scans. Two other rats had little to no uptake; SUVR values were ∼70% lower than IV SUVR. These latter two animals showed heavy bone uptake, evidence of defluorination of FAL. The results of this pilot study suggest that it may be possible to achieve striatal uptake of FAL after IP injection. However, this was not seen consistently across animals. Future studies are needed to validate, and then to optimize, the use of IP FAL for behavioral imaging protocols.

KW - Behavioral neuroimaging

KW - D2 receptor

KW - Dopamine

KW - Fallypride

KW - Positron emission tomography

KW - Small animal imaging

UR - http://www.scopus.com/inward/record.url?scp=79951553657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951553657&partnerID=8YFLogxK

U2 - 10.1016/j.jneumeth.2010.12.027

DO - 10.1016/j.jneumeth.2010.12.027

M3 - Article

VL - 196

SP - 70

EP - 75

JO - Journal of Neuroscience Methods

JF - Journal of Neuroscience Methods

SN - 0165-0270

IS - 1

ER -